1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Dual Reuptake Inhibitor Trial

Last updated on May 12, 2023

Dual Reuptake Inhibitor TrialDuloxetine reduces symptoms of depression.

Duloxetine, an investi-gational antidepressant agent, called a dual reuptake inhibitor, was shown to be superior to placebo in reducing the severity of depressive symptoms. The Phase II data came from a multisite trial of 173 patients with major depression who randomly received either duloxetine, fluoxetine or placebo for eight weeks. The drug was well-tolerated.

Leave a Reply
Notify of